Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,030 | 3 | 43.3% |
| Food and Beverage | $1,956 | 82 | 41.8% |
| Long term medical supply or device loan | $598.20 | 6 | 12.8% |
| Education | $99.00 | 1 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,281 | 3 | $0 (2023) |
| Daiichi Sankyo Inc. | $920.47 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $643.91 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $253.80 | 3 | $0 (2024) |
| Seagen Inc. | $231.10 | 5 | $0 (2023) |
| PFIZER INC. | $218.84 | 14 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $176.56 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $150.04 | 9 | $0 (2024) |
| UROGEN PHARMA, INC. | $138.59 | 2 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $119.50 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,201 | 38 | Daiichi Sankyo Inc. ($901.08) |
| 2023 | $491.70 | 18 | AstraZeneca Pharmaceuticals LP ($120.91) |
| 2022 | $1,397 | 15 | AstraZeneca Pharmaceuticals LP ($1,160) |
| 2021 | $593.27 | 21 | Janssen Pharmaceuticals, Inc ($233.76) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Daiichi Sankyo Inc. | — | Consulting Fee | Cash or cash equivalent | $580.00 | General |
| 12/05/2024 | Daiichi Sankyo Inc. | — | Consulting Fee | Cash or cash equivalent | $290.00 | General |
| 12/05/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 10/08/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Oncology | ||||||
| 09/27/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.33 | General |
| 08/23/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 08/02/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: Oncology | ||||||
| 08/01/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Oncology | ||||||
| 07/29/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 07/18/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Oncology | ||||||
| 07/16/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: ONCOLOGY | ||||||
| 07/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $99.70 | General |
| Category: Oncology | ||||||
| 07/15/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $44.09 | General |
| Category: UROTHELIAL CANCER | ||||||
| 07/13/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $94.50 | General |
| Category: UROTHELIAL CANCER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,493 | 2,623 | $322,466 | $63,843 |
| 2022 | 20 | 1,515 | 2,972 | $370,688 | $77,202 |
| 2021 | 18 | 1,223 | 2,151 | $216,509 | $46,444 |
| 2020 | 18 | 954 | 1,722 | $262,305 | $29,644 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 307 | $125,691 | $22,809 | 18.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 293 | 435 | $125,239 | $21,871 | 17.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 230 | 459 | $13,591 | $3,760 | 27.7% |
| 80076 | Liver function blood test panel | Office | 2023 | 222 | 441 | $12,613 | $3,489 | 27.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 232 | 459 | $12,485 | $3,452 | 27.7% |
| 82378 | Carcinoembryonic antigen (cea) protein level | Office | 2023 | 72 | 97 | $6,437 | $1,802 | 28.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 13 | $7,474 | $1,472 | 19.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 33 | 90 | $5,292 | $1,437 | 27.2% |
| 86300 | Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | Office | 2023 | 43 | 52 | $3,788 | $1,060 | 28.0% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 25 | 41 | $2,639 | $723.82 | 27.4% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 32 | 40 | $1,908 | $523.27 | 27.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 18 | 22 | $1,161 | $312.86 | 26.9% |
| 83550 | Iron binding capacity | Office | 2023 | 29 | 36 | $1,101 | $301.39 | 27.4% |
| 83540 | Iron level | Office | 2023 | 29 | 36 | $815.40 | $222.97 | 27.3% |
| 82565 | Blood creatinine level | Office | 2023 | 27 | 43 | $770.56 | $203.32 | 26.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 23 | $670.28 | $193.20 | 28.8% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 16 | 17 | $536.69 | $142.92 | 26.6% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 12 | 12 | $253.68 | $66.11 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 162 | 312 | $123,930 | $23,929 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 293 | 453 | $124,575 | $23,411 | 18.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 48 | $26,496 | $5,135 | 19.4% |
| 99358 | Extended patient service without direct patient contact, first hour | Office | 2022 | 71 | 71 | $23,963 | $4,866 | 20.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 208 | 536 | $14,579 | $4,040 | 27.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 195 | 491 | $14,539 | $4,024 | 27.7% |
| 80076 | Liver function blood test panel | Office | 2022 | 189 | 477 | $13,642 | $3,789 | 27.8% |
About Heather Greene, NP
Heather Greene, NP is a Family healthcare provider based in Germantown, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902873045.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Heather Greene, NP has received a total of $4,683 in payments from pharmaceutical and medical device companies, with $2,201 received in 2024. These payments were reported across 92 transactions from 25 companies. The most common payment nature is "Consulting Fee" ($2,030).
As a Medicare-enrolled provider, Greene has provided services to 5,185 Medicare beneficiaries, totaling 9,468 services with total Medicare billing of $217,133. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Germantown, TN
- Active Since 03/08/2006
- Last Updated 05/11/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1902873045
Products in Payments
- LYNPARZA (Drug) $1,262
- KISQALI (Drug) $598.20
- XARELTO (Drug) $253.80
- Onivyde (Drug) $176.56
- KEYTRUDA (Biological) $150.04
- JELMYTO (Drug) $138.59
- PADCEV (Biological) $132.10
- XTANDI (Drug) $107.04
- Udenyca (Biological) $106.96
- INLYTA (Drug) $100.86
- Nubeqa (Drug) $93.66
- IMBRUVICA (Drug) $74.23
- Enhertu (Drug) $50.47
- PLUVICTO (Drug) $45.71
- CABOMETYX (Drug) $43.80
- VERZENIO (Drug) $42.65
- LONSURF (Drug) $40.04
- LIBTAYO (Biological) $38.62
- Trodelvy (Drug) $31.36
- IBRANCE (Drug) $28.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Germantown
Chantil Jeffreys, Dnp, DNP
Family — Payments: $125,057
Dr. Angela Ugwuanyi, Dnp, Np-C, DNP, NP-C
Family — Payments: $13,865
Mrs. Kristen Page, Np, NP
Family — Payments: $11,984
Ms. Elizabeth Phillips, Fnp, FNP
Family — Payments: $11,106
Emily Hoffmann, Np, NP
Family — Payments: $10,047
Mrs. Christy Thornhill, Np, NP
Family — Payments: $8,421